Stocknear Logo Stocknear
/
Popular
Login

CRISPR Therapeutics AG

38.31
-0.80 (-2.05%)
At close: Apr 25, 2025, 3:59 PM
38.38
0.18%
After-hours: Apr 25, 2025, 05:54 PM EDT

CRISPR Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-366.25M -153.61M -650.17M 377.66M -348.87M 66.86M -164.98M -68.36M -23.2M
19.26M 19.84M 24.17M 17.95M 9.18M 4.72M 3.52M 3.02M 925K
86.57M 81.03M 97.95M 102.39M 66.02M 44.06M 34.98M 18.87M 10.84M
-18.73M 3.33M 14.38M 27.02M 33.48M -48.42M -1M -21.24M 1.83M
-38.62M -14.04M 12.47M 14.11M 1.86M -10.53M 15.41M 1.75M 8.05M
n/a n/a n/a n/a n/a n/a 4.28M n/a -53.71M
156.27M -193.59M 19.84M 26.86M 33.44M -48.43M 10.55M -25.39M 1.78M
-142.77M -260.38M -495.74M 538.97M -238.37M 56.68M -96.24M -70.1M -55.31M
-1.9M -11.97M -37.19M -81.7M -18.36M -6.68M -2.77M -7.81M -3.02M
n/a n/a 221.47M 953.73M 522.81M 8.01M n/a n/a -100K
-1.46B -1.07B -1.42B -1.51B -594M n/a n/a -500K -100K
1.21B 1.45B 1.2B 555.6M 71.19M n/a n/a n/a n/a
-23.18M -2.5M -221.47M -953.73M -522.81M 8.01M n/a -500K 35M
-280.48M 374.65M -258.65M -1.04B -541.17M 1.32M -2.77M -8.31M 31.88M
n/a n/a n/a n/a n/a n/a n/a n/a 35.01M
n/a n/a n/a n/a n/a n/a -57K n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
31.29M 29.94M 37.62M 37.68M 33.86M 15.96M 8.94M 2.61M -1.78M
331.98M 62.66M 38.59M 250.94M 1.02B 430.98M 315.93M 2.61M 183.22M
-91.29M 177.01M -715.88M -245.52M 236.66M 489M 216.9M -75.76M 159.56M
-144.68M -272.35M -532.93M 457.27M -256.72M 49.99M -99.01M -77.91M -58.33M

Create Price Alert on CRSP

Your price alert will notify you when the stock price is above 38.31.

Add to Watchlist